HIV

A new research and licensing partnership between the University of Pennsylvania and Novartis aims to develop more effective treatments for cancer by giving patients a disabled form of HIV.

Findings of a new study suggest women infected with HIV do not need more frequent Pap tests.

Treatment with antiretrovirals is now recommended for all adults with HIV infection, regardless of their CD4 count.

The initiative will provide greater insight into how the patient-pharmacist relationship can help improve retention in care, adherence and viral suppression outcomes.

The FDA approved Truvada for preexposure prophylaxis, making it the first agent ever to be approved for HIV prevention in uninfected adults.

The FDA today approved OraQuick In-Home HIV Test, the first over-the-counter HIV test that gives users results without having to send samples off to a lab.

Pharmacies and retail clinics are offering HIV testing in an effort to help reach the CDC's goal of testing every adolescent and adult in the country.

Pharmacies and retail clinics are offering HIV testing in an effort to help reach the CDC's goal of testing every adolescent and adult in the country.

The FDA will take an additional 3 months to review the drug application for Truvada as a preventive HIV treatment to account for updated safety materials submitted by Gilead.

An FDA advisory panel has recommended Truvada as a pre-exposure prophylaxis for people at risk of contracting HIV.

Access to food and shelter, rather than viral load count, is a better predictor of overall health among homeless HIV-infected men, according to a recent study.

New combination pills set to hit the market are expected to be more expensive than prior treatments.

The new guidelines offer detailed information on interactions between antiepileptic drugs and antiretroviral drugs.

Patients taking antiretroviral therapy can maximize their therapy when pharmacists educate them about their medication regimens.

Patients taking antiretroviral therapy can maximize their therapy when pharmacists educate them about their medication regimens.

The FDA sent out a "Drug Safety Communication" from their Division of Drug Information on February 9, 2012, listing the important new drug interactions between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitor drugs.

Thirty years after the AIDS virus was first reported, significant advances in therapy have been made. But there are still too many who aren't being treated.